This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
with Julien Lefranc We asked one of our reviewers, Julien Lefranc, about what inspires and excites him about drug discovery.…
Article
9 months ago ●
4 mins read
An old molecule and an old target come together. Squalamine was originally discovered in 1993 as an antimicrobial from the…
molecule
3 months ago ●
3 mins read
A fat-tissue-targeting clinical candidate, a first-in-class Ph. III molecule that inhibits its target by covalently modifying the target’s substrate, and…
Article
10 months ago ●
1 min read
The first approved EGFR exon 20 mutant inhibitor. While there are now three generations of EGFR inhibitors approved, patients harboring…
molecule
3 months ago ●
6 mins read
Our first South San Francisco Drug Hunter event was so much fun, we've decided to host in-person events all over…
Article
10 months ago ●
2 mins read
Overcoming FGFR mutation resistance and FGFR1-mediated hyperphosphatemia toxicity through isoform-selective FGFR2/3 inhibition. “Compound 29” is an ATP-competitive fibroblast growth factor…
molecule
3 months ago ●
3 mins read
Load More
